Company that seeks to develop innovative biological solutions for the control of agricultural pests and diseases, ensuring its technical, regulatory, and productive viability.
• General Characteristics
- ACTIVITY: Wholesale non-specialized sales.
- LOCATION: Lima, Peru.
- DATE OF INCORPORATION: 01/08/1976
- CATEGORY: Agricultural industry and nutrition and animal health.
- CONTACT: 983 871 505
- WEB: https://www.corpmontana.com/
• Business Structure
- NUMBER OF EMPLOYEES: 383
- REVENUES: >100 million USD
- COMMERCIAL DESCRIPTION: MONTANA is a regional corporation with over six decades of experience dedicated to the development, manufacturing, and marketing of comprehensive solutions for agriculture, animal nutrition and health, and environmental biosecurity. Its portfolio includes agricultural inputs such as fertilizers, biostimulants, insecticides, and fungicides, formulated to optimize crop performance and enhance plant health. In the livestock sector, it offers nutritional additives, premixes, vitamins, minerals, and veterinary products aimed at improving health, welfare, and productivity in cattle, poultry, and swine.
- BUSINESS LINES: Agriculture, Nutrition and animal health, Biosecurity and environmental health
- INFRASTRUCTURE:
- 1. Molecular Research and Bioscience Laboratory equipped with modern technologies for research, development, and innovation (R&D&i).
- 2. Production plant.
- 3. Warehouses.
- 4 administrative offices.
- 5. Biopesticide pilot plant
- INTEREST DATA: MONTANA is a corporation with over 60 years of experience, primarily present in Peru and Ecuador, with expansion to various countries in Latin America. It also promotes sustainability programs, technical training, and sector events for the benefit of its clients and producer communities. It has an online information channel and training content called M-Conecta that offers technical information (articles, guides, or notes) on topics of interest for producers and professionals in the sector.
• R&D Activities/Interests
TECHNOLOGICAL OFFER/DEMAND:
- Complement internal capabilities: microorganisms (fungi, bacteria, consortia) and genomics, metabolomics, and molecular biology.
- Co-development and/or technological validation (collaborative projects for laboratory, greenhouse, and field trials).
- Detect patents, emerging research lines, and disruptive technologies. Identify encapsulation technologies, carriers, adjuvants, and controlled release.
- Access to funding and R&D+i calls.
• Participation in projects
PROJECTS UNDER DEVELOPMENT
- Production of secondary metabolites from Beauveria bassiana for nanoencapsulation.
- Preparation of biological biostimulants based on algae.
- Preparation of biological products based on microbial consortia with multiple targets.
- Detection of compounds or metabolites from plant extracts for the generation of products for crop protection.
COMPLETED PROJECTS
- Biological biofungicides from native Peruvian strains / Self-funding